{"id":210125,"name":"BRISTOL MYERS SQUIBB","slug":"bristol-myers-squibb","state":"NY","country":"United States of America","description":"Global biopharma company developing innovative medicines","totalSpending":1220000,"filings":22,"yearlySpending":[{"year":2021,"income":200000},{"year":2022,"income":300000},{"year":2023,"income":240000},{"year":2024,"income":220000},{"year":2025,"income":260000}],"issues":[{"code":"MMM","display":"Medicare/Medicaid"},{"code":"BUD","display":"Budget/Appropriations"},{"code":"HCR","display":"Health Issues"}],"firms":["TARPLIN, DOWNS & YOUNG, LLC"],"lobbyists":["RAISSA DOWNS","JENNIFER YOUNG","MICHELLE EASTON","ELIZABETH MURRAY","CHARLOTTE IVANCIC","PAMELA SMITH","EMILY MURRY","KIMBERLY BRANDT","MARGARET JOSEPH","PETER FISE","LAURA FRIEDEL","PARICK CARROLL"],"govEntities":["HOUSE OF REPRESENTATIVES","SENATE","Centers For Medicare and Medicaid Services (CMS)","White House Office"],"sampleDescriptions":["Prescription drug access, User Fee Reauthorization, Innovation","Prescription drug access, User Fee Reauthorization, Innovation","Prescription drug access, User Fee Reauthorization, Innovation","reconciliation, FY2022 budget, appropriations","prescription drug access and affordability, pricing, transparency\nH.R. 1319, American Rescue Pan of 2021 implementation"]}